Fundraising Fox

Soligenix

NASDAQ: SNGX

Princeton, US · Delaware corporation · 1 known investors

Founders & leadership

RC
Richard C. Straube, MD MScExecutive
KK
Karen KrumeichExecutive
OD
Oreola Donini, PhDExecutive
CJ
Christopher J. Schaber, PhDExecutive
AT
Adam T. RumageNamed on SEC filing
RC
R. Christopher Cavalli, PhDNamed on SEC filing
MM
Marco M. Brughera, DVMNamed on SEC filing

Board

KL
Keith L. Brownlie, CPABoard director
JB
Jerome B. Zeldis, PhDBoard director
GA
Gregg A. LaPointe, CPABoard director
RJ
Robert J. Rubin, MDBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 1 round · 2017

$2MraisedNov 2017 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam T. RumageExecutive Officer
  • Richard C. Straube, MD MScExecutive Officer
  • Karen KrumeichExecutive Officer
  • Oreola Donini, PhDExecutive Officer
  • Keith L. Brownlie, CPADirector
  • Jerome B. Zeldis, PhDDirector
  • Gregg A. LaPointe, CPADirector
  • Robert J. Rubin, MDDirector
  • R. Christopher Cavalli, PhDExecutive Officer
  • Marco M. Brughera, DVMDirector
  • Christopher J. Schaber, PhDExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
Finders' fees
$137.5K
Placement agents
Aegis Capital Corp.
First sale
Nov 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Soligenix for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 11 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$150K
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase II2017$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$300K
National Institutes of Health (NIH)National Institutes of HealthPhase I2014$225K
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$600K
National Institutes of Health (NIH)National Institutes of HealthPhase I2012$300K
National Institutes of Health (NIH)National Institutes of HealthPhase I2009$509.9K
National Institutes of Health (NIH)National Institutes of HealthPhase I2006$470.5K
National Institutes of Health (NIH)National Institutes of HealthPhase I2003$149.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

Who are Soligenix's investors?
Soligenix's investors include Pontifax Venture Capital.
How much funding has Soligenix raised?
Soligenix has disclosed $2M raised across 1 round.
Where is Soligenix headquartered?
Soligenix is headquartered in Princeton, US.